NCT02251054

Brief Summary

This study compares the efficacy of embedding avatars into an online self-management program that teaches OAB behavioral therapy on OAB-related quality of life, symptoms, self-efficacy, and adherence versus the same program without avatars

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
47

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2012

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2012

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2013

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2013

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

September 24, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 26, 2014

Completed
Last Updated

September 26, 2014

Status Verified

September 1, 2014

Enrollment Period

9 months

First QC Date

September 24, 2014

Last Update Submit

September 24, 2014

Conditions

Keywords

Overactive BladderMultimediaBehavioral Therapy

Outcome Measures

Primary Outcomes (1)

  • Overactive bladder- health related quality of life (OAB HRQOL)

    The OAB-q is a 33-item measure to assess impact of OAB symptoms on HRQOL. The OAB-q consists of a symptom bother scale and four HRQOL subscales (coping, concern, sleep, and social interaction). All scale scores are transformed to a 0-to-100-point scale, with higher symptom bother scores indicating greater symptom severity, and lower total and subscale scores indicating improvement in HRQOL.27 A 10-point change in these scales indicates a minimal clinically important difference (MCID). The Cronbach alpha coefficient in this study was 0.88.

    Baseline and at one, six, and 12 weeks

Secondary Outcomes (5)

  • Perception of Bladder Condition (PPBC)

    Baseline and at one, six, and 12 weeks

  • Overactive bladder symptoms

    12 weeks duration

  • Geriatric Self-Efficacy Index for Urinary Incontinence (GSEI)

    Baseline and at one, six, and 12 weeks

  • Adherence to Pelvic Floor Muscle Exercises (PFMEs)

    Baseline and at one, six, and 12 weeks

  • Avatar Recognition

    At 12 weeks

Study Arms (2)

Avatar group

EXPERIMENTAL

Intervention group viewed two avatar coaches: a generic avatar coach (GAC) and a self-avatar, "peer" mentor (SAP).

Other: Avatar group

No Avatar group

ACTIVE COMPARATOR

The control group version (voice only) observed the identical program, including introductions, question asking, narration of animations, delivery of key points, and summary of each section with identical pre-recorded voices without the avatars.

Other: No Avatar group

Interventions

We developed and tested the online program of three multimedia tutorials using the game development and rendering engine (Unity3D, Unity Technologies, San Francisco, CA). This arm saw the tutorials with Avatars.

Avatar group

We developed and tested the online program of three multimedia tutorials using the game development and rendering engine (Unity3D, Unity Technologies, San Francisco, CA). This arm saw the tutorials without Avatars.

No Avatar group

Eligibility Criteria

Age55 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age 55 or older
  • women living in the community
  • who could read and speak English
  • urgency (≥3 episodes/24 hrs.) ± urge urinary incontinence
  • urinary frequency (≥8 times/24 hrs.)
  • nocturia (awakening ≥2 times at night)

You may not qualify if:

  • hematuria
  • abdominal pain
  • fever
  • cognitive impairment (Mini-Cog \< 3)
  • positive screen for depression (PHQ2 \> 3)
  • hearing issues
  • uncorrected visual difficulties

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Miami VA Healthcare System

Miami, Florida, 33125, United States

Location

Related Publications (1)

  • Andrade AD, Anam R, Karanam C, Downey P, Ruiz JG. An overactive bladder online self-management program with embedded avatars: a randomized controlled trial of efficacy. Urology. 2015 Mar;85(3):561-7. doi: 10.1016/j.urology.2014.11.017. Epub 2015 Jan 10.

MeSH Terms

Conditions

Urinary Bladder, Overactive

Condition Hierarchy (Ancestors)

Urinary Bladder DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Allen D Andrade, MD

    Miami VAHS

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Staff physician

Study Record Dates

First Submitted

September 24, 2014

First Posted

September 26, 2014

Study Start

October 1, 2012

Primary Completion

July 1, 2013

Study Completion

October 1, 2013

Last Updated

September 26, 2014

Record last verified: 2014-09

Locations